Cell biology of tight junction barrier regulation and mucosal disease

Cold Spring Harbor Perspectives in Biology

Volumn 10, Issue 1, 2018, Pages

  Buckley, Aaron ^a   Turner, Jerrold R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 13; MYOSIN LIGHT CHAIN KINASE; PROTEIN ZO1; TJP1 PROTEIN, HUMAN;

ANATOMY AND HISTOLOGY; ANIMAL; CHEMISTRY; HUMAN; INTESTINE MUCOSA; MUCOSA; MUCOSAL IMMUNITY; PERMEABILITY; PHYSIOLOGY; TIGHT JUNCTION;

ANIMALS; HUMANS; IMMUNITY, MUCOSAL; INTERLEUKIN-13; INTESTINAL MUCOSA; MUCOUS MEMBRANE; MYOSIN-LIGHT-CHAIN KINASE; PERMEABILITY; TIGHT JUNCTIONS; ZONULA OCCLUDENS-1 PROTEIN;

EID: 85040100676     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a029314     Document Type: Article

References (124)

1. Al-Sadi R, Khatib K, Guo S, Ye D, Youssef M, Ma T. 2011. Occludin regulates macromolecule flux across the intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 300: G1054-1064.
2. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, Fromm M. 2002. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115: 4969-4976.
3. Amasheh S, Fromm M, Gunzel D. 2011. Claudins of intestine and nephron—a correlation of molecular tight junction structure and barrier function. Acta Physiol (Oxf) 201: 133-140.
4. Anderson JM, Van Itallie CM. 2009. Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 1: a002584.
5. Angelow S, Schneeberger EE, Yu AS. 2007. Claudin-8 expression in renal epithelial cells augments the paracellular barrier by replacing endogenous claudin-2. J Membr Biol 215: 147-159.
6. Bain J, McLauchlan H, Elliott M, Cohen P. 2003. The spec-ificities of protein kinase inhibitors: An update. Biochem J 371: 199-204.
7. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, et al. 2007. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003- 1007.
8. Bevins CL, Salzman NH. 2011. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9: 356-368.
9. Blair SA, Kane SV, Clayburgh DR, Turner JR. 2006. Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease. Lab Invest 86: 191-201.
10. Bondow BJ, Faber ML, Wojta KJ, Walker EM, Battle MA. 2012. E-cadherin is required for intestinal morphogenesis in the mouse. Dev Biol 371: 1-12.
11. Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF, Stappenbeck TS. 2007. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 117: 258-269.
12. Buschmann MM, Shen L, Rajapakse H, Raleigh DR, Wang Y, Wang Y, Lingaraju A, Zha J, Abbott E, McAuley EM, et al. 2013. Occludin OCEL-domain interactions are required for maintenance and regulation of the tight junction barrier to macromolecular flux. Mol Biol Cell 24: 3056- 3068.
13. Carlton VE, Harris BZ, Puffenberger EG, Batta AK, Knisely AS, Robinson DL, Strauss KA, Shneider BL, Lim WA, Salen G, et al. 2003. Complex inheritance of familial hy-percholanemia with associated mutations in TJP2 and BAAT. Nat Genet 34: 91-96.
14. Cereijido M, Contreras RG, Shoshani L, Flores-Benitez D, Larre I. 2008. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biophys Acta 1778: 770-793.
15. Chen Y, Merzdorf C, Paul DL, Goodenough DA. 1997. COOH terminus of occludin is required for tight junction barrier function in early Xenopus embryos. J Cell Biol 138: 891-899.
16. Chen C, Tao T, Wen C, He WQ, Qiao YN, Gao YQ, Chen X, Wang P, Chen CP, Zhao W, et al. 2014. Myosin light chain kinase (MLCK) regulates cell migration in a myosin regulatory light chain phosphorylation-independent mechanism. J Biol Chem 289: 28478-28488.
17. Chung H, Pamp SJ, Hill JA, Surana NK, Edelman SM, Troy EB, Reading NC, Villablanca EJ, Wang S, Mora JR, et al. 2012. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149: 1578-1593.
18. Citi S, Sabanay H, Jakes R, Geiger B, Kendrick-Jones J. 1988. Cingulin, a new peripheral component of tight junctions. Nature 333: 272-276.
19. Claude P. 1978. Morphological factors influencing transepithelial permeability: A model for the resistance of the zonula occludens. J Membr Biol 39: 219-232.
20. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. 2005. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J Clin Invest 115: 2702-2715.
21. Colegio OR, Van Itallie C, Rahner C, Anderson JM. 2003. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am J Physiol Cell Physiol 284: C1346-1354.
22. Collins FS. 1992. Cystic fibrosis: Molecular biology and therapeutic implications. Science 256: 774-779.
23. Cordenonsi M, Mazzon E, De Rigo L, Baraldo S, Meggio F, Citi S. 1997. Occludin dephosphorylation in early development of Xenopus laevis. J Cell Sci 110: 3131-3139.
24. d’Hennezel E, Ben-Shoshan M, Ochs HD, Torgerson TR, Russell LJ, Lejtenyi C, Noya FJ, Jabado N, Mazer B, Picci-rillo CA. 2009. FOXP3 forkhead domain mutation and regulatory T cells in the IPEX syndrome. N Engl J Med 361: 1710-1713.
25. Dorfel MJ, Westphal JK, Bellmann C, Krug SM, Cording J, Mittag S, Tauber R, Fromm M, Blasig IE, Huber O. 2013. CK2-dependent phosphorylation of occludin regulates the interaction with ZO-proteins and tight junction integrity. Cell Commun Signal 11: 40.
26. Fanning AS, Ma TY, Anderson JM. 2002. Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J 16: 1835-1837.
27. Farquhar M, Palade G. 1963. Junctional complexes in various epithelia. J Cell Biol 17: 375-412.
28. Ferraris RP, Diamond J. 1997. Regulation of intestinal sugar transport. Physiol Rev 77: 257-302.
29. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S. 1993. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123: 1777-1788.
30. Furuse M, Fujimoto K, Sato N, Hirase T, Tsukita S. 1996. Overexpression of occludin, a tight junction-associated integral membrane protein, induces the formation of intracellular multilamellar bodies bearing tight junction-like structures. J Cell Sci 109: 429-435.
31. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. 1998a. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141: 1539-1550.
32. Furuse M, Sasaki H, Fujimoto K, Tsukita S. 1998b. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 143: 391-401.
33. Furuse M, Furuse K, Sasaki H, Tsukita S. 2001. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153: 263-272.
34. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugi-tani Y, Noda T, Kubo A, Tsukita S. 2002. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice. J Cell Biol 156: 1099-1111.
35. Gabriel SE, Brigman KN, Koller BH, Boucher RC, Stutts MJ. 1994. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266: 107-109.
36. Glocker EO, Kotlarz D, Boztug K, Gertz EM, Schaffer AA, Noyan F, Perro M, Diestelhorst J, Allroth A, Murugan D, et al. 2009. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361: 2033-2045.
37. Gong Y, Renigunta V, Zhou Y, Sunq A, Wang J, Yang J, Renigunta A, Baker LA, Hou J. 2015. Biochemical and biophysical analyses of tight junction permeability made of claudin-16 and claudin-19 dimerization. Mol Biol Cell 26: 4333-4346.
38. Gumbiner BM. 1993. Breaking through the tight junction barrier. J Cell Biol 123: 1631-1633.
39. Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Hadchouel M, et al. 2004. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyo-sis: A tight junction disease. Gastroenterol 127: 1386- 1390.
40. Hayes P, Dhillon S, O’Neill K, Thoeni C, Hui KY, Elkadri A, Guo CH, Kovacic L, Aviello G, Alvarez LA, et al. 2015. Defects in NADPH oxidase genes NOX1 and DUOX2 in very early onset inflammatory bowel disease. Cell Mol Gastroenterol Hepatol 1: 489-502.
41. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Burgel N, Fromm M, et al. 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterol 129: 550-564.
42. Hermiston ML, Gordon JI. 1995. In vivo analysis of cadherin function in the mouse intestinal epithelium: Essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol 129: 489-506.
43. Hermiston ML, Wong MH, Gordon JI. 1996. Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonauton-omous regulation of cell fate in a self-renewing system. Genes Dev 10: 985-996.
44. Herrmann JR, Turner JR. 2016. Beyond Ussing’s chambers: Contemporary thoughts on integration of transepithelial transport. Am J Physiol Cell Physiol 310: C423-431.
45. Higashi T, Katsuno T, Kitajiri S, Furuse M. 2015. Deficiency of angulin-2/ILDR1, a tricellular tight junction-associated membrane protein, causes deafness with cochlear hair cell degeneration in mice. PLoS ONE 10: e0120674.
46. Higashi T, Tokuda S, Kitajiri S, Masuda S, Nakamura H, Oda Y, Furuse M. 2013. Analysis of the ’angulin’ proteins LSR, ILDR1 and ILDR2-tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis. J Cell Sci 126: 966-977.
47. Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. 2006. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 6: 581-588.
48. Hooper LV, Littman DR, Macpherson AJ. 2012. Interactions between the microbiota and the immune system. Science 336: 1268-1273.
49. Hwang ES, Hirayama BA, Wright EM. 1991. Distribution of the SGLT1 Na+/glucose cotransporter and mRNA along the crypt-villus axis of rabbit small intestine. Biochem Biophys Res Commun 181: 1208-1217.
50. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. 2005. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 171: 939-945.
51. Ikenouchi J, Sasaki H, Tsukita S, Furuse M, Tsukita S. 2008. Loss of occludin affects tricellular localization of tricellulin. Mol Biol Cell 19: 4687-4693.
52. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. 1999. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147: 1351-1363.
53. Kato A, Romero MF. 2011. Regulation of electroneutral NaCl absorption by the small intestine. Annu Rev Physiol 73: 261-281.
54. Kiesler P, Fuss IJ, Strober W. 2015. Experimental Models of inflammatory bowel diseases. Cell Mol Gastroenterol Hepatol 1: 154-170.
55. Kim KS, Hong SW, Han D, Yi J, Jung J, Yang BG, Lee JY, Lee M, Surh CD. 2016. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351: 858-863.
56. Kim NK, Higashi T, Lee KY, Kim AR, Kitajiri S, Kim MY, Chang MY, Kim V, Oh SH, Kim D, et al. 2015. Down-sloping high-frequency hearing loss due to inner ear tricellular tight junction disruption by a novel ILDR1 mutation in the Ig-like domain. PLoS ONE 10: e0116931.
57. Kitajiri S, Katsuno T, Sasaki H, Ito J, Furuse M, Tsukita S. 2014. Deafness in occludin-deficient mice with dislocation of tricellulin and progressive apoptosis of the hair cells. Biol Open 3: 759-766.
58. Kohlnhofer BM, Thompson CA, Walker EM, Battle MA. 2016. GATA4 regulates epithelial cell proliferation to control intestinal growth and development in mice. Cell Mol Gastroenterol Hepatol 2: 189-209.
59. Krug SM, Amasheh S, Richter JF, Milatz S, Gunzel D, Westphal JK, Huber O, Schulzke JD, Fromm M. 2009. Tricellulin forms a barrier to macromolecules in tricellular tight junctions without affecting ion permeability. Mol Biol Cell 20: 3713-3724.
60. Krug SM, Schulzke JD, Fromm M. 2014. Tight junction, selective permeability, and related diseases. Semin Cell Dev Biol 36: 166-176.
61. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin-10-deficient mice develop chronic enteroco-litis. Cell 75: 263-274.
62. Li J, Zhuo M, Pei L, Rajagopal M, Yu AS. 2014. Comprehensive cysteine-scanning mutagenesis reveals Claudin-2 pore-lining residues with different intrapore locations. J Biol Chem 289: 6475-6484.
63. Lingaraju A, Long TM, Wang Y, Austin JRII, Turner JR. 2015. Conceptual barriers to understanding physical barriers. Semin Cell Dev Biol 42: 13-21.
64. Liu F, Koval M, Ranganathan S, Fanayan S, Hancock WS, Lundberg EK, Beavis RC, Lane L, Duek P, McQuade L, et al. 2016. Systems proteomics view of the endogenous human claudin protein family. J Proteome Res 15: 339- 359.
65. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. 2005. Mechanism of TNF-a modulation of Caco-2 intestinal epithelial tight junction barrier: Role of myosin light-chain kinase protein expression. Am J Physiol - Gastrointest Liver Physiol 288: G422-430.
66. Mankertz J, Amasheh M, Krug SM, Fromm A, Amasheh S, Hillenbrand B, Tavalali S, Fromm M, Schulzke JD. 2009. TNFa up-regulates claudin-2 expression in epithelial HT-29/B6 cells via phosphatidylinositol-3-kinase signaling. Cell Tissue Res 336: 67-77.
67. Marchiando AM, Graham WV, Turner JR. 2010a. Epithelial barriers in homeostasis and disease. Annu Rev Pathol 5: 119-144.
68. Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JRII, Raleigh DR, Guan Y, Watson AJ, Montrose MH, et al. 2010b. Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo. J Cell Biol 189: 111-126.
69. Matter K, Balda MS. 1999. Occludin and the functions of tight junctions. Int Rev Cytol 186: 117-146.
70. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE. 1996. Occludin is a functional component of the tight junction. J Cell Sci 109: 2287-2298.
71. Mishima Y, Liu B, Hansen JJ, Sartor RB. 2015. Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signaling. Cell Mol Gastroenterol Hepatol 1: 295- 310.
72. Morita K, Furuse M, Fujimoto K, Tsukita S. 1999. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci 96: 511-516.
73. Muto S, Hata M, Taniguchi J, Tsuruoka S, Moriwaki K, Saitou M, Furuse K, Sasaki H, Fujimura A, Imai M, et al. 2010. Claudin-2-deficient mice are defective in the leaky and cation-selective paracellular permeability properties of renal proximal tubules. Proc Natl Acad Sci 107: 8011- 8016.
74. Nayak G, Lee SI, Yousaf R, Edelmann SE, Trincot C, Van Itallie CM, Sinha GP, Rafeeq M, Jones SM, Belyantseva IA, et al. 2013. Tricellulin deficiency affects tight junction architecture and cochlear hair cells. J Clin Invest 123: 4036-4049.
75. Naydenov NG, Feygin A, Wang D, Kuemmerle JF, Harris G, Conti MA, Adelstein RS, Ivanov AI. 2016. Nonmuscle myosin IIA regulates intestinal epithelial barrier in vivo and plays a protective role during experimental colitis. Sci Rep 6: 24161.
76. Odenwald MA, Choi W, Buckley A, Shashikanth N, Joseph NE, Wang Y, Warren MH, Buschmann MM, Pavlyuk R, Hildebrand J, et al. 2016. ZO-1 interactions with F-actin and occludin direct epithelial polarization and single lumen specification in 3D culture. J Cell Sci 130: 243-259.
77. Pei L, Solis G, Nguyen MT, Kamat N, Magenheimer L, Zhuo M, Li J, Curry J, McDonough AA, Fields TA, et al. 2016. Paracellular epithelial sodium transport maximizes energy efficiency in the kidney. J Clin Invest 126: 2509-2518.
78. Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, Higginbotham JN, Juchheim A, Prasad N, Levy SE, et al. 2012. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149: 146-158.
79. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. 1993. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 5: 1461-1471.
80. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553-562.
81. Raleigh DR, Marchiando AM, Zhang Y, Shen L, Sasaki H, Wang Y, Long M, Turner JR. 2010. Tight junction-associated MARVEL proteins marveld3, tricellulin, and occludin have distinct but overlapping functions. Mol Biol Cell 21: 1200-1213.
82. Raleigh DR, Boe DM, Yu D, Weber CR, Marchiando AM, Bradford EM, Wang Y, Wu L, Schneeberger EE, Shen L, et al. 2011. Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function. J Cell Biol 193: 565-582.
83. Riazuddin S, Ahmed ZM, Fanning AS, Lagziel A, Kitajiri S, Ramzan K, Khan SN, Chattaraj P, Friedman PL, Anderson JM, et al. 2006. Tricellulin is a tight-junction protein necessary for hearing. Am J Hum Genet 79: 1040-1051.
84. Russo JM, Florian P, Shen L, Graham WV, Tretiakova MS, Gitter AH, Mrsny RJ, Turner JR. 2005. Distinct temporal-spatial roles for r kinase and myosin light chain kinase in epithelial purse-string wound closure. Gastroenterol 128: 987-1001.
85. Saitou M, Fujimoto K, Doi Y, Itoh M, Fujimoto T, Furuse M, Takano H, Noda T, Tsukita S. 1998. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 141: 397- 408.
86. Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, Takano H, Noda T, Tsukita S. 2000. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11: 4131-4142.
87. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S. 1997. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137: 1393-1401.
88. Schlingmann B, Overgaard CE, Molina SA, Lynn KS, Mitchell LA, Dorsainvil White S, Mattheyses AL, Guidot DM, Capaldo CT, Koval M. 2016. Regulation of claudin/ zonula occludens-1 complexes by hetero-claudin interactions. Nat Commun 7: 12276.
89. Schwarz BT, Wang F, Shen L, Clayburgh DR, Su L, Wang Y, Fu YX, Turner JR. 2007. LIGHT signals directly to intestinal epithelia to cause barrier dysfunction via cytoskeletal and endocytic mechanisms. Gastroenterol 132: 2383- 2394.
90. Shen L, Turner JR. 2005. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol Biol Cell 16: 3919-3936.
91. Shen L, Weber CR, Turner JR. 2008. The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol 181: 683- 695.
92. Shen L, Weber CR, Raleigh DR, Yu D, Turner JR. 2011. Tight junction pore and leak pathways: A dynamic duo. Annu Rev Physiol 73: 283-309.
93. 2+ resorption. Science 285: 103-106.
94. Smales C, Ellis M, Baumber R, Hussain N, Desmond H, Staddon JM. 2003. Occludin phosphorylation: identification of an occludin kinase in brain and cell extracts as CK2. FEBS Lett 545: 161-166.
95. Staehelin LA. 1973. Further observations on the fine structure of freeze-cleaved tight junctions. J Cell Sci 13: 763- 786.
96. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. 1986. Identification of ZO-1: A high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103: 755-766.
97. Stevenson BR, Anderson JM, Goodenough DA, Mooseker MS. 1988. Tight junction structure and ZO-1 content are identical in two strains of Madin-Darby canine kidney cells which differ in transepithelial resistance. J Cell Biol 107: 2401-2408.
98. Su L, Shen L, Clayburgh DR, Nalle SC, Sullivan EA, Meddings JB, Abraham C, Turner JR. 2009. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterol 136: 551-563.
99. Su L, Nalle SC, Shen L, Turner ES, Singh G, Breskin LA, Khramtsova EA, Khramtsova G, Tsai PY, Fu YX, et al. 2013. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterol 145: 407-415.
100. Tamura A, Hayashi H, Imasato M, Yamazaki Y, Hagiwara A, Wada M, Noda T, Watanabe M, Suzuki Y, Tsukita S. 2011. Loss of claudin-15, but not claudin-2, causes Na+ deficiency and glucose malabsorption in mouse small intestine. Gastroenterol 140: 913-923.
101. Tash BR, Bewley MC, Russo M, Keil JM, Griffin KA, Sund-strom JM, Antonetti DA, Tian F, Flanagan JM. 2012. The occludin and ZO-1 complex, defined by small angle X-ray scattering and NMR, has implications for modulating tight junction permeability. Proc Natl Acad Sci 109: 10855-10860.
102. Turner JR. 2009. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 9: 799-809.
103. Turner JR. 2016. Epithelia and gastrointestinal function. In Yamada’s Textbook of Gastroenterology (eds. Podolsky DK, et al.), pp. 317-329. John Wiley & Sons, NJ.
104. Turner JR, Rill BK, Carlson SL, Carnes D, Kerner R, Mrsny RJ, Madara JL. 1997. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am J Physiol 273: C1378-1385.
105. Turner JR, Buschmann MM, Romero-Calvo I, Sailer A, Shen L. 2014. The role of molecular remodeling in differential regulation of tight junction permeability. Semin Cell Dev Biol 36: 204-212.
106. Van Itallie CM, Anderson JM. 2012. Caveolin binds independently to claudin-2 and occludin. Ann N Y Acad Sci 1257: 103-107.
107. Van Itallie C, Rahner C, Anderson JM. 2001. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107: 1319-1327.
108. Van Itallie CM, Holmes J, Bridges A, Gookin JL, Coccaro MR, Proctor W, Colegio OR, Anderson JM. 2008. The density of small tight junction pores varies among cell types and is increased by expression of claudin-2. J Cell Sci 121: 298-305.
109. Van Itallie CM, Fanning AS, Bridges A, Anderson JM. 2009. ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell 20: 3930-3940.
110. Van Itallie CM, Fanning AS, Holmes J, Anderson JM. 2010. Occludin is required for cytokine-induced regulation of tight junction barriers. J Cell Sci 123: 2844-2852.
111. Wada M, Tamura A, Takahashi N, Tsukita S. 2013. Loss of claudins 2 and 15 from mice causes defects in paracellular Na+ flow and nutrient transport in gut and leads to death from malnutrition. Gastroenterol 144: 369-380.
112. Wang F, Graham WV, Wang Y, Witkowski ED, Schwarz BT, Turner JR. 2005. Interferon-g and tumor necrosis factor-a synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am J Pathol 166: 409-419.
113. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, Abraham C, Turner JR. 2006. IFN-g-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterol 131: 1153-1163.
114. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. 2008. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 88: 1110-1120.
115. Weber CR, Raleigh DR, Su L, Shen L, Sullivan EA, Wang Y, Turner JR. 2010. Epithelial myosin light chain kinase activation induces mucosal interleukin-13 expression to alter tight junction ion selectivity. J Biol Chem 285: 12037-12046.
116. Weber CR, Liang GH, Wang Y, Das S, Shen L, Yu AS, Nelson DJ, Turner JR. 2015. Claudin-2-dependent paracellular channels are dynamically gated. eLife 4: e09906.
117. Weber CR, Turner JR. 2017. Dynamic modeling of the tight junction pore pathway. Ann N Y Acad Sci (in press).
118. Wilcox ER, Burton QL, Naz S, Riazuddin S, Smith TN, Ploplis B, Belyantseva I, Ben-Yosef T, Liburd NA, Morell RJ, et al. 2001. Mutations in the gene encoding tight junction claudin-14 cause autosomal recessive deafness DFNB29. Cell 104: 165-172.
119. Wong V. 1997. Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 273: C1859-1867.
120. Wong V, Gumbiner BM. 1997. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136: 399-409.
121. Wong VW, Stange DE, Page ME, Buczacki S, Wabik A, Itami S, van de Wetering M, Poulsom R, Wright NA, Trotter MW, et al. 2012. Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling. Nat Cell Biol 14: 401-408.
122. Yu AS, McCarthy KM, Francis SA, McCormack JM, Lai J, Rogers RA, Lynch RD, Schneeberger EE. 2005. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am J Physiol Cell Physiol 288: C1231-1241.
123. Yu D, Marchiando AM, Weber CR, Raleigh DR, Wang Y, Shen L, Turner JR. 2010. MLCK-dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function. Proc Natl Acad Sci 107: 8237-8241.
124. Zolotarevsky Y, Hecht G, Koutsouris A, Gonzalez DE, Quan C, Tom J, Mrsny RJ, Turner JR. 2002. A membrane-per-meant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterol 123: 163-172.